Evidence map›Paper›PMID 37663753›Full record

Article3 Biotech2023

Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity.

Ritika Khatri, Bharat Lohiya, Gurleen Kaur, Vikas Maithil, Abhishek Goswami, Debapriyo Sarmadhikari, Shailendra Asthana, Sweety Samal

Open access · greenAbstract read
In one paragraph

Article in 3 Biotech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ritika KhatriTranslational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001 India.
Bharat LohiyaTranslational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001 India.
Gurleen KaurTranslational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001 India.
Vikas MaithilTranslational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001 India.
Abhishek GoswamiTranslational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001 India.
Debapriyo SarmadhikariTranslational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001 India.
Shailendra AsthanaTranslational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001 India.
Sweety SamalTranslational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001 India.ORCID 0000-0001-7894-8756
Translational Health Science and Technology Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spike (S) glycoprotein of the SARS-CoV-2 virus binds to the host cell receptor and promotes the virus's entry into the target host cell. This interaction is primed by host cell proteases like furin and TMPRSS2, which act at the S1/S2 and S2´ cleavage sites, respectively. Both cleavage sites have serine or proline residues flanking either the single or polybasic region and were found to be conserved in coronaviruses. Unravelling the effects of these conserved residues on the virus entry and infectivity might facilitate the development of novel therapeutics. Here, we have investigated the role of the conserved serine and proline residues in the SARS-CoV-2 spike mediated entry, fusogenicity, and viral infectivity by using the HIV-1/spike-based pseudovirus system. A conserved serine residue mutation to alanine (S2´S-A) at the S2´ cleavage site resulted in the complete loss of spike cleavage. Exogenous treatment with trypsin or overexpression of TMPRSS2 protease could not rescue the loss of spike cleavage and biological activity. The S2´S-A mutant showed no significant responses against E-64d, TMPRSS2 or other relevant inhibitors. Taken together, serine at the S2´ site in the spike protein was indispensable for spike protein cleavage and virus infectivity. Thus, novel interventions targeting the conserved serine at the S2´ cleavage site should be explored to reduce severe disease caused by SARS-CoV-2-and novel emerging variants. Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-023-03749-y.

Indexed as

Cell entry and viral infectivityConserved serineSARS-CoV-2Spike cleavage site

Identifiers

PMID37663753
PMCPMC10469153
OpenAlexW4386289511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.